# Trade Mark Journal No.2025/031 1 August 2025

## WO0000001853788 (5,42)

Office of origin: United States of America

Date of International Registration:12 March 2025
Date of designation in the UK: 12 March 2025

The mark consists of the wording "IMMUNOME" in a stylized font below three drops positioned in a triangular pattern. A stylized triangle separates each drop.

International priority date claimed: 30 September 2024 (United States of America) (98778646)

Class 5
  Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders.
Class 42
  Biotechnology services, namely, development of monoclonal antibodies and antibody drug conjugates; pharmaceutical, medical, scientific, biopharmaceutical and biotechnology research and development; drug discovery services; providing medical and scientific research information in the field of medicine and pharmaceuticals.

Immunome, Inc.

Representative: Lori J. Shyavitz, Esq. McCarter & English, LLP, 265 Franklin Street, Boston MA 02110-3113, UNITED STATES OF AMERICA